Cite
HARVARD Citation
Shinde, V. et al. (2021). Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine. Clinical infectious diseases. pp. e4278-e4287. [Online].